BioCentury
ARTICLE | Financial News

Revance financial update

June 30, 2014 7:00 AM UTC

Revance Therapeutics Inc. (NASDAQ:RVNC), Newark, Calif. Business: Dermatology Date announced:2014-06-24 Note: Revance raised $18.3 million through the sale of 600,000 shares at $30.50 to cover the ove...